vs

Side-by-side financial comparison of LIQUIDITY SERVICES INC (LQDT) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

Ultragenyx Pharmaceutical Inc. is the larger business by last-quarter revenue ($207.3M vs $121.2M, roughly 1.7× LIQUIDITY SERVICES INC). LIQUIDITY SERVICES INC runs the higher net margin — 6.2% vs -62.0%, a 68.2% gap on every dollar of revenue. On growth, Ultragenyx Pharmaceutical Inc. posted the faster year-over-year revenue change (25.9% vs -0.9%). LIQUIDITY SERVICES INC produced more free cash flow last quarter ($-2.8M vs $-100.8M). Over the past eight quarters, Ultragenyx Pharmaceutical Inc.'s revenue compounded faster (38.0% CAGR vs 15.1%).

Liquidity Services, Inc. is an American e-commerce company providing surplus asset management services through a network of online marketplaces. It serves businesses and government agencies by facilitating the resale of surplus, returned, and end-of-life goods. Founded in 1999 and headquartered in Bethesda, Maryland, United States.

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

LQDT vs RARE — Head-to-Head

Bigger by revenue
RARE
RARE
1.7× larger
RARE
$207.3M
$121.2M
LQDT
Growing faster (revenue YoY)
RARE
RARE
+26.8% gap
RARE
25.9%
-0.9%
LQDT
Higher net margin
LQDT
LQDT
68.2% more per $
LQDT
6.2%
-62.0%
RARE
More free cash flow
LQDT
LQDT
$98.0M more FCF
LQDT
$-2.8M
$-100.8M
RARE
Faster 2-yr revenue CAGR
RARE
RARE
Annualised
RARE
38.0%
15.1%
LQDT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LQDT
LQDT
RARE
RARE
Revenue
$121.2M
$207.3M
Net Profit
$7.5M
$-128.6M
Gross Margin
47.0%
Operating Margin
7.7%
-54.7%
Net Margin
6.2%
-62.0%
Revenue YoY
-0.9%
25.9%
Net Profit YoY
28.9%
3.5%
EPS (diluted)
$0.23
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LQDT
LQDT
RARE
RARE
Q4 25
$121.2M
$207.3M
Q3 25
$118.1M
$159.9M
Q2 25
$119.9M
$166.5M
Q1 25
$116.4M
$139.3M
Q4 24
$122.3M
$164.6M
Q3 24
$106.9M
$139.5M
Q2 24
$93.6M
$147.0M
Q1 24
$91.5M
$108.8M
Net Profit
LQDT
LQDT
RARE
RARE
Q4 25
$7.5M
$-128.6M
Q3 25
$7.8M
$-180.4M
Q2 25
$7.4M
$-115.0M
Q1 25
$7.1M
$-151.1M
Q4 24
$5.8M
$-133.2M
Q3 24
$6.4M
$-133.5M
Q2 24
$6.0M
$-131.6M
Q1 24
$5.7M
$-170.7M
Gross Margin
LQDT
LQDT
RARE
RARE
Q4 25
47.0%
Q3 25
47.8%
Q2 25
45.7%
Q1 25
40.8%
Q4 24
41.0%
Q3 24
45.6%
Q2 24
52.8%
Q1 24
51.6%
Operating Margin
LQDT
LQDT
RARE
RARE
Q4 25
7.7%
-54.7%
Q3 25
9.3%
-106.9%
Q2 25
8.5%
-64.8%
Q1 25
5.8%
-102.6%
Q4 24
5.8%
-74.3%
Q3 24
6.8%
-94.6%
Q2 24
8.4%
-79.1%
Q1 24
7.2%
-151.9%
Net Margin
LQDT
LQDT
RARE
RARE
Q4 25
6.2%
-62.0%
Q3 25
6.6%
-112.8%
Q2 25
6.2%
-69.0%
Q1 25
6.1%
-108.5%
Q4 24
4.7%
-80.9%
Q3 24
6.0%
-95.7%
Q2 24
6.4%
-89.5%
Q1 24
6.2%
-156.8%
EPS (diluted)
LQDT
LQDT
RARE
RARE
Q4 25
$0.23
$-1.28
Q3 25
$0.24
$-1.81
Q2 25
$0.23
$-1.17
Q1 25
$0.22
$-1.57
Q4 24
$0.18
$-1.34
Q3 24
$0.20
$-1.40
Q2 24
$0.19
$-1.52
Q1 24
$0.18
$-2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LQDT
LQDT
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$11.6M
$421.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$215.3M
$-80.0M
Total Assets
$369.1M
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LQDT
LQDT
RARE
RARE
Q4 25
$11.6M
$421.0M
Q3 25
$11.2M
$202.5M
Q2 25
$11.4M
$176.3M
Q1 25
$10.5M
$127.1M
Q4 24
$10.4M
$174.0M
Q3 24
$2.3M
$150.6M
Q2 24
$6.5M
$480.7M
Q1 24
$8.4M
$112.3M
Stockholders' Equity
LQDT
LQDT
RARE
RARE
Q4 25
$215.3M
$-80.0M
Q3 25
$203.2M
$9.2M
Q2 25
$208.7M
$151.3M
Q1 25
$196.3M
$144.2M
Q4 24
$189.2M
$255.0M
Q3 24
$182.6M
$346.8M
Q2 24
$172.0M
$432.4M
Q1 24
$163.9M
$140.3M
Total Assets
LQDT
LQDT
RARE
RARE
Q4 25
$369.1M
$1.5B
Q3 25
$375.1M
$1.2B
Q2 25
$372.4M
$1.3B
Q1 25
$358.8M
$1.3B
Q4 24
$333.2M
$1.5B
Q3 24
$346.9M
$1.5B
Q2 24
$325.5M
$1.6B
Q1 24
$303.7M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LQDT
LQDT
RARE
RARE
Operating Cash FlowLast quarter
$-526.0K
$-99.8M
Free Cash FlowOCF − Capex
$-2.8M
$-100.8M
FCF MarginFCF / Revenue
-2.3%
-48.6%
Capex IntensityCapex / Revenue
1.9%
0.5%
Cash ConversionOCF / Net Profit
-0.07×
TTM Free Cash FlowTrailing 4 quarters
$70.1M
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LQDT
LQDT
RARE
RARE
Q4 25
$-526.0K
$-99.8M
Q3 25
$38.0M
$-91.4M
Q2 25
$19.3M
$-108.3M
Q1 25
$21.6M
$-166.5M
Q4 24
$-12.1M
$-79.3M
Q3 24
$22.0M
$-67.0M
Q2 24
$22.2M
$-77.0M
Q1 24
$34.8M
$-190.7M
Free Cash Flow
LQDT
LQDT
RARE
RARE
Q4 25
$-2.8M
$-100.8M
Q3 25
$36.0M
$-92.7M
Q2 25
$17.2M
$-110.7M
Q1 25
$19.8M
$-167.8M
Q4 24
$-14.0M
$-79.5M
Q3 24
$19.2M
$-68.6M
Q2 24
$20.3M
$-79.0M
Q1 24
$32.5M
$-193.9M
FCF Margin
LQDT
LQDT
RARE
RARE
Q4 25
-2.3%
-48.6%
Q3 25
30.5%
-58.0%
Q2 25
14.3%
-66.5%
Q1 25
17.0%
-120.5%
Q4 24
-11.4%
-48.3%
Q3 24
17.9%
-49.2%
Q2 24
21.7%
-53.7%
Q1 24
35.5%
-178.2%
Capex Intensity
LQDT
LQDT
RARE
RARE
Q4 25
1.9%
0.5%
Q3 25
1.7%
0.8%
Q2 25
1.8%
1.5%
Q1 25
1.6%
1.0%
Q4 24
1.5%
0.1%
Q3 24
2.7%
1.2%
Q2 24
2.1%
1.4%
Q1 24
2.6%
3.0%
Cash Conversion
LQDT
LQDT
RARE
RARE
Q4 25
-0.07×
Q3 25
4.86×
Q2 25
2.60×
Q1 25
3.07×
Q4 24
-2.09×
Q3 24
3.45×
Q2 24
3.71×
Q1 24
6.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LQDT
LQDT

RSCG$82.0M68%
Gov Deals$22.3M18%
CAG$11.5M9%
Machinio And Software Solutions Corporation$5.5M5%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons